Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration: report of a case.
Daily administration of large doses of factor VIII concentrate in a hemophiliac with a high titer factor VIII inhibitor resulted in marked reduction in the titer and response of the inhibitor to factor VIII administration and made possible elbow and bilateral knee replacements under conventional factor VIII coverage. Studies performed during the course of treatment indicated that the reduction in the inhibitor was the result of specific tolerance to factor VIII.
D000328:Adult; D001323:Autoantibodies / Q000276:immunology*; D004551:Elbow Joint; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007595:Joint Prosthesis; D007720:Knee Prosthesis; D008297:Male
D001323:Autoantibodies; D005169:Factor VIII